Rosetta Genomics, Ltd. (ROSG)
-NasdaqCM 3.95 
0.04(1.00%) 11:23AM EDT - Nasdaq Real Time Price
| Prev Close: | 3.99 |
|---|
| Open: | 4.02 |
|---|
| Bid: | 3.95 x 1000 |
|---|
| Ask: | 4.01 x 500 |
|---|
| 1y Target Est: | 10.00 |
|---|
| Beta: | -3.88 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 3.86 - 4.04 |
|---|
| 52wk Range: | 3.09 - 17.50 |
|---|
| Volume: | 147,543 |
|---|
| Avg Vol (3m): | 260,694 |
|---|
| Market Cap: | 35.93M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.35 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Rosetta Genomics to Present at the Jefferies 2013 Healthcare ConferencePR Newswire(Wed, May 22)
- BRIEF-Rosetta Genomics up 11.8 percent in premarket tradeat Reuters(Mon, May 20)
- Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2PR Newswire(Mon, May 20)
- Rosetta Genomics Receives Full Settlement Payment from Sanra LaboratoriesPR Newswire(Fri, May 10)
- Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual MeetingPR Newswire(Tue, May 7)
- Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical LaboratoriesPR Newswire(Thu, Apr 18)
- Rosetta Genomics Business Update Call scheduled for 10:00 am ET todayCCBN(Wed, Apr 10)
- 4 Health Care Stocks Under $10 to Watchat TheStreet(Tue, Apr 2)
- Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013PR Newswire(Tue, Apr 2)
- 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet(Mon, Apr 1)
- Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular OncologyPR Newswire(Mon, Apr 1)
- ROSETTA GENOMICS LTD. FinancialsEDGAR Online Financials(Fri, Mar 29)
- Rosetta Genomics To Host Business Update Conference Call on April 10, 2013PR Newswire(Mon, Mar 25)
- Rosetta Genomics' CEO Presents at 25th Annual ROTH Conference - Transcriptat Seeking Alpha(Wed, Mar 20)
- Rosetta Genomics receives U.S. patent allowanceat theflyonthewall.com(Mon, Mar 18)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 180.58 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-11)
: | N/A |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Rosetta Genomics Ltd. develops and commercializes a range of microRNA-based diagnostic tools. MicroRNAs are a group of genes that are produced using instructions encoded in DNA.
View More